Clinical Trials Directory

Trials / Terminated

TerminatedNCT06341725

EUS Role in Non-metastatic Pancreatic Adenocarcinoma Lymph Nodes Staging

Role of Endoscopic Ultrasound to Assess the Lymph Nodes Staging in Non-metastatic Pancreatic Adenocarcinoma

Status
Terminated
Phase
Study type
Observational
Enrollment
2 (actual)
Sponsor
Paolo Giorgio Arcidiacono, MD · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Aim of the study will be to investigate if Endoscopic Ultrasound (EUS) with elastography can be purposed between the routine staging examinations in patients with pancreatic adenocarcinoma without distant metastasis for the staging of lymph nodes status ("N" in TNM classification) * in RESECTABLE pancreatic cancer the investigators will evaluate the concordance with EUS elastography and histological findings of lymph nodes obtained during surgery, in order to assess the sensibility, specificity and the positive and negative predictive value of EUS with elastography, the disease-free survival, the percentage of metastatic patients and the overall survival (in patients with or without metastatic lymph nodes). * in "BORDERLINE resectable" and UNRESECTABLE non-metastatic ("advanced" locally") disease, the investigators will evaluate if the malignant lymph nodes samples during EUS with elastography and fine needle aspiration (FNA) will be related to a decreased survival. Secondary aim will be to register the prognosis (in terms of survival) of the patients with para-aortic and mediastinal pathological lymph nodes (related to a decreases survival in some series in literature)

Detailed description

Pathological lymph nodes will be assessed by EUS with elastography as lymph nodes: hypoechoic, rounded, rigid (blue) and big (bigger than 1 centimeter)

Conditions

Interventions

TypeNameDescription
OTHERmalignant lymph nodesobservational study

Timeline

Start date
2018-02-15
Primary completion
2018-02-15
Completion
2018-09-11
First posted
2024-04-02
Last updated
2024-04-02

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06341725. Inclusion in this directory is not an endorsement.